Clenil discontinuation in November 2026

Clenil® 50microgram inhalers and Clenil® 250microgram inhalers are being discontinued in November 2026, and a coordinated local response is required to support safe switching across Kent and Medway. This was communicated to all medical professionals via an MSN briefing (MSN/2026/038) on 25th August. The main operational risk is that patients may remain being prescribed Clenil® 50microgram and 250microgram beyond the discontinuation date, reducing adherence to essential inhaled corticosteroids during the winter months, and beyond.

83% of patients currently prescribed Clenil® 50 microgram inhalers are under the age of 20 years, and are more susceptible to asthma exacerbations during the winter months.

Please ensure all patients are aware that their inhalers will be switched to an alternative due to the discontinuation, and reassure that the inhaler is equivalent in dose and inhalation technique.